4.7 Article

Ojeoksan Ameliorates Cisplatin-Induced Acute Kidney Injury in Mice by Downregulating MAPK and NF-κB Pathways

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Ojeok-san ameliorates visceral and somatic nociception in a mouse model of colitis induced colorectal cancer

Patrice Cunningham et al.

Summary: Cancer patients often experience pain and fatigue, and they may turn to complementary and alternative medicine for relief. A herbal formula called Ojeok-san (OJS) has been found to possess anti-inflammatory, immunoregulatory, and analgesic properties. This study found that OJS can alleviate pain in a mouse model of colitis-associated colorectal cancer without affecting symptom score and tumor burden.

PLOS ONE (2022)

Article Medicine, Research & Experimental

Formononetin protects against cisplatin-induced acute kidney injury through activation of the PPARα/Nrf2/HO-1/NQO1 pathway

Yan Hao et al.

Summary: This study demonstrated that FOR protects against CIS-induced AKI through activation of the PPAR alpha/Nrf2/HO-1/NQO1 pathway. Additionally, FOR and eupatilin promote cell viability and antioxidant enzyme activity, while showing significant inhibitory effects on apoptosis and inflammatory factors in HK-2 cells.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Chemistry, Multidisciplinary

Natural products: potential treatments for cisplatin-induced nephrotoxicity

Chun-yan Fang et al.

Summary: Cisplatin is a clinically advanced anticancer drug, but its severe nephrotoxic effects limit its clinical use. There are currently no effective drugs for cisplatin-induced kidney injury, but natural products may have potential therapeutic effects.

ACTA PHARMACOLOGICA SINICA (2021)

Article Biochemistry & Molecular Biology

Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice

Dong-Uk Kim et al.

Summary: The study demonstrates that loganin can attenuate cisplatin-induced acute kidney injury through inhibiting renal damage, inflammatory cytokines release, and cell apoptosis, among other pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations

Kristen Renee McSweeney et al.

Summary: This article summarizes the characteristics of nephrotoxicity in cisplatin treatment, the pathophysiological mechanisms of kidney injury, and the current research on pharmacological treatment options to reduce AKI. Despite years of research, interventions, and clinical trials, there is still a lack of consistent pharmacological treatment options for cisplatin-induced acute kidney injury.

CANCERS (2021)

Article Nutrition & Dietetics

Ferulic Acid Metabolites Attenuate LPS-Induced Inflammatory Response in Enterocyte-like Cells

Gabriele Serreli et al.

Summary: Ferulic acid and its metabolites show efficacy in combating inflammation by limiting the expression and activity of proinflammatory enzymes, reducing NF-κB translocation, and promoting Nrf2 expression.

NUTRIENTS (2021)

Review Chemistry, Inorganic & Nuclear

The side effects of platinum-based chemotherapy drugs: a review for chemists

Rabbab Oun et al.

DALTON TRANSACTIONS (2018)

Article Nutrition & Dietetics

The Inhibitory Effect of Ojeoksan on Early and Advanced Atherosclerosis

Byung Hyuk Han et al.

NUTRIENTS (2018)

Article Biochemistry & Molecular Biology

Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury

Tess V. Dupre et al.

JOURNAL OF LIPID RESEARCH (2017)

Article Medicine, Research & Experimental

Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect

Jinghong Yu et al.

LIFE SCIENCES (2017)

Article Transplantation

Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection

Blanca Humanes et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)

Article Integrative & Complementary Medicine

Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats

Jianyu Zhou et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)

Article Oncology

CXCL16 regulates cisplatin-induced acute kidney injury

Hua Liang et al.

ONCOTARGET (2016)

Article Critical Care Medicine

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

Eric A. J. Hoste et al.

INTENSIVE CARE MEDICINE (2015)

Review Toxicology

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

Takatoshi Karasawa et al.

TOXICOLOGY LETTERS (2015)

Review Medical Laboratory Technology

Overview of Urea and Creatinine

Jose H. Salazar

LABMEDICINE (2014)

Review Biotechnology & Applied Microbiology

Pathophysiology of Cisplatin-Induced Acute Kidney Injury

Abdullah Ozkok et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Pharmacology & Pharmacy

The Water-Soluble Triptolide Derivative PG490-88 Protects against Cisplatin-Induced Acute Kidney Injury

Hyun-Jung Kim et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)

Article Urology & Nephrology

Onco-Nephrology: AKI in the Cancer Patient

Albert Q. Lam et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

Review Food Science & Technology

Mechanisms of Cisplatin Nephrotoxicity

Ronald P. Miller et al.

TOXINS (2010)

Review Pharmacology & Pharmacy

Biomarkers of acute kidney injury

Vishal S. Vaidya et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)

Review Urology & Nephrology

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

N. Pabla et al.

KIDNEY INTERNATIONAL (2008)

Article Medicine, Research & Experimental

The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro

Chia-Chou Yeh et al.

LIFE SCIENCES (2007)

Article Physiology

p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice

G Ramesh et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)

Article Urology & Nephrology

Spectrum of acute renal failure in the intensive care unit: The PICARD experience

RL Mehta et al.

KIDNEY INTERNATIONAL (2004)

Article Pharmacology & Pharmacy

Role of cysteine S-conjugate β-lyase in the metabolism of cisplatin

L Zhang et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Article Urology & Nephrology

Hospital-acquired renal insufficiency

K Nash et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2002)